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Menaquinone-7, also known as vitamin K2, is a lipid-soluble
molecule that, in humans, plays a crucial role in blood coagulation,
bone metabolism, and calciﬁcation of arteries [1–6]. Bacteria of the
large intestine synthesize menaquinone-7 (hereafter simpliﬁed to
‘‘menaquinone’’) for use as an electron transporter in anaerobic
respiration [7,8]. Humans do not synthesize menaquinone but ac-
quire it from their diet and intestinal ﬂora [9]. Because the menqui-
none biosynthetic pathway is restricted to bacteria, the enzymes
that function in this pathway are potential targets for the develop-
ment of novel antibiotics [10–14]. Thus, the elucidation of the
chemical steps of the menaquinone pathway and the catalytic
mechanisms of the enzyme catalysts are important objectives.Historically, the Escherichia coli menaquinone pathway and the
structures and mechanisms of the pathway enzymes have been the
focus of investigation [15–25]. Nevertheless the menaquinone
pathways of other bacteria have been characterized [26–28], some
of which employ different biosynthetic strategies [29]. In the ﬁrst
step of the upper pathway (Fig. 1a), chorismate, derived from the
shikimate pathway, is converted to isochorismate by MenF, an
isochorismate synthase. In the second step 2-succinyl-5-eno-
lpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate is formed by
the action of the thiamine-dependent enzyme MenD. MenH, a
member of the a,b-fold hydrolase family, has recently been shown
to catalyze the elimination of the pyruvyl-substituent from this
intermediate. The product 2-succinyl-6-hydroxy-2,4-cyclohexadi-
ene-1-carboxylate, is converted through the elimination of H2O
to 2-succinylbenzoate as catalyzed by MenC, a member of the enolase
superfamily. The succinyl side chain of 2-succinylbenzoate is acti-
vated for cyclization through the action of the ligase MenE that cat-
alyzes the transformation of the carboxylate group to the coenzyme
A (CoA) thioester. The naphthoquinol skeleton of 1,4-dihydroxy-
napthoyl-CoA is generated via a cyclization reaction catalyzed by
1,4-dihydroxynaphthoyl-CoA synthase, MenB, a member of the
crotonase family. The genes encoding these six enzymes in E. coli are
co-located (Fig. 1B). The 1,4-dihydroxynapthoyl-CoA is then hydro-
lyzed by a thioesterase of the hotdog-fold family [30–32]. In the
Fig. 1. A: The chemical steps of the E. coli menaquinone biosynthetic pathway. B: The menaquinone biosynthetic pathway gene cluster in E. coli K-12 and in B. fragilis. The
E. coli genes menf, mend, menh, menb, menc, and mene encode isochorismate synthase, 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase, 2-
succinyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase, 2-succinylbenzoate synthase, 2-succinylbenzoate:CoA ligase, and napthoate synthase, respectively. The B. fragilis
gene cluster is annotated based on the sequence homology to the E. coli K-12 genes. The two ‘‘extra genes’’ BF1314 and BF1317 encode the fusion protein and a hypothetical
protein, respectfully.
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napthoate in two steps. First, the polyprenyl unit from octaprenyl-
pyrophosphate is added in a reaction catalyzed by MenA [33].
Second, the napthyl ring is methylated by reaction with S-adeno-
sylmethionine as catalyzed by MenG [34].
Our interest in the biochemical basis for adaptation by bacteria
that colonize the human internal cavity lead us to a comparative
analysis of the meniquinone gene clusters among the genomes of
Bacteroidetes species. These species constitute a large fraction of
the human gut bacterial community. Homologs to all E. coli upper
pathway genes were found in these species with the exception of
MenH. Most signiﬁcant was the discovery of an additional gene
that co-locates with the meniquinone gene cluster in a large num-
ber of the Bacteroidetes species (Fig. 1B). This gene encodes a fu-
sion protein consisting of an N-terminal domain that is
homologous to the class C2B haloacid dehalogenase (HAD) enzyme
superfamily phosphatases and a C-terminal domain that is homol-
ogous to type AB thioesterases of the hotdog-fold enzyme super-
family. Our ﬁrst objective was to demonstrate that the hotdog-
fold domain catalyzes the hydrolysis of the menaquinone pathway
1,4-dihydroxynapthoyl-CoA to 1,4-dihydroxynapthoate, and by
doing so complete the set of pathway catalysts. Our second objec-
tive was to determine the function of the appended HAD domain
and its relationship to the menaquinone pathway. Our approach
to this problem represents the merging of the kinetic analyses en-
abled by Michaelis and Menton [35] (see [36] for a translation)
100 years ago and the bioinformatic methods that have become
available in the genomic era.
Herein, we provide the results from steady-state kinetic analy-
ses of the targeted gene product derived from two different Bacter-
oidetes species, which establish the identity of the menaquinone
pathway thioesterase and which deﬁne the role of the HADphosphatase domain as an oligomerization domain. In addition,
through comprehensive bioinformatic analysis we track the two
domains throughout Bacteroidetes to provide insight into the path-
way for evolution of the fusion protein.
2. Materials and methods
2.1. Materials
Unless otherwise stated, all chemicals were obtained from Sig-
ma–Aldrich. Primers, T4 DNA ligase, and restriction enzymes were
purchased from Invitrogen, Pfu and Pfu Turbo polymerases were
from Stratagene, the pET-14a, and pET23a, pET28a and pET28b vec-
tor kitswere fromNovagen, and theGeneclean Spin and theQiaprep
Spin Miniprep kits were from Qiagen. Genomic DNA from Bacteroi-
des thetaiotaomicron VPI-5482 (ATCC-29148D), Porphyromonas
gingivalis W83, Bacteroides fragilis and Bacteroides vulgatus were
from ATCC. DEAE Sepharose was from Amersham Biosciences.
Butyryl-CoA, isobutyryl-CoA, hexanoyl-CoA, octanoyl-CoA, deca-
noyl-CoA, myristoryl-CoA and benzoyl-CoA were purchased from
Sigma–Aldrich. The phosphate esters and anhydrides were pur-
chased from Sigma–Aldrich. The 4-hydroxybenzoyl-CoA and 3-
hydroxyphenylacetyl-CoAwere synthesized according to published
procedures [37–40]. Napthoyl-CoA and 1,4-dihydroxynapthoyl-
CoA were synthesized as detailed in Supporting Information.
2.2. Gene cloning and expression and protein puriﬁcation
The genes encoding the BT4699 (NCBI accession NP_813610,
UniProt accession Q89YN2), PG1653 (NCBI accession NP_905773,
UniProt accession Q7MU91), BF1314 (NCBI accession YP_098598,
UniProt accession Q5LFS7) and BVU2420 (NCBI accession
M. Wang et al. / FEBS Letters 587 (2013) 2851–2859 2853YP_001299701, UniProt accession A6L315) were ampliﬁed from
the genomic DNA derived from B. thetaiotaomicron, P. gingivalis
W83, B. fragilis and B. vulgatus, respectively, using PCR techniques
in combination with commercial primers that contain the endo-
nuclease cleavage sites Nde I and Xho I. The PCR products were
puriﬁed and then subcloned into a pET-28a vector, which adds a
His6 tag to the N-terminus of each protein. Plasmid DNA was puri-
ﬁed using a Qiaprep Spin Miniprep Kit. The identity of the sub-
cloned genes was demonstrated by full-length DNA sequencing
(University of New Mexico).
Transformed E. coli BL21 (DE3) competent cells were grown at
37 C for 6 h in 3 L of LB media containing 50 lg/ml of kanamycin
with shaking at 220 rpm. The cells were induced with 0.2 mM iso-
propyl-1-thio-b-D-galactopyranoside (IPTG) with shaking at
170 rpm for 12 h at 20 C. The cells were harvested by centrifuga-
tion (6500 rpm for 15 min at 4 C), resuspended in 300 ml of lysis
buffer (50 mM N-(2-hydroxyethyl)piperazine-N0-2-ethanesulfo-
nate (HEPES), 300 mM NaCl, 10 mM imidazole, pH 8.0) and lysed
by 2 passages through a French Press cell (12,000 psi). The cell ly-
sate was centrifuged at 20,000 rpm for 60 min at 4 C. The BT4699
proved to be insoluble and was not pursued further. The respective
BF1314, PG1653, and BVU2420-containing supernatants were sep-
arately chromatographed on Ni-afﬁnity columns. The columns
were washed with 200 ml of lysis buffer followed by 200 ml of
wash buffer (50 mM HEPES, 300 mM NaCl, 20 mM imidazole, pH
8.0) before eluting the His6-tagged protein with 100 ml of elution
buffer (50 mM HEPES, 300 mM NaCl, 250 mM imidazole, pH 8.0).
The protein containing fractions were concentrated by using a
10 kDa Macrosep centricon (Pall Filtron) and then dialyzed against
50 mM HEPES, 300 mM NaCl (pH 7.5) at 4 C. The His6-tag was
cleaved from BVU2420 to enhance its solubility at lower salt con-
centration (viz. 50 mM NaCl). Accordingly, 30 ll of thrombin
(500 U/ml) were added to the concentrated protein solution at
room temperature (25 C) and the resulting solution was incubated
overnight and then passed through a Ni afﬁnity column. The eluate
was dialyzed at 4 C in 50 mM HEPES and 50 mM NaCl (pH 7.5).
The protein concentration was determined by using the Brad-
ford assay and also, by measuring the solution absorption at
280 nm. Protein purity was veriﬁed by SDS–PAGE to be greater
than 95% with ﬁnal yields as follows: BF1314 (1.2 mg/g wet cells),
PG1653 (1.7 mg/g wet cells) and BVU2420 (5.0 mg/g wet cells).
2.3. Preparation of PG1653 truncation mutants
The HAD domain and the thioesterase domain of the fusion pro-
tein PG1653 were prepared as truncation constructs using Quick-
change site-directed mutagenesis. To generate the HAD domain
the codon for Val271 was mutated to the stop codon TAA. Oligonu-
cleotide primers 50-CGA ATA TGA AGC CTA ACC TTT CTC CGT AGA-
30 (forward), and 50-TCT ACG GAG AAA GGT TAG GCT TCA TAT TCG-
30 (reverse) were used in the PCR reaction. To generate the thioes-
terase domain the Pro272 codon was mutated to a start codon. Oli-
gonucleotide primers 50-TAT GAA GCC CAT ATG TTC TCC GTA GAA-
30 (forward) and 50-ATG GGA AAA AAG CTT TTA CCG CTG TTC AGG-
30 (reverse) were used in the PCR reactions. The respective PCR
products were cloned into the PET-28b vector, which was used
to transform competent E. coli BL21 (DE3) cells as described in
the previous section. Puriﬁcation of the truncation mutants was
carried out as described for the wild-type PG1653.
2.4. Native molecular weight determination
Chromatography was performed using a ÄKTA P-920 FPLC sys-
tem equipped with a Hiprep 16/60 Sephacryl S-200 HR column (GE
Healthcare). The size exclusion column was equilibrated with
50 mM HEPES (pH 7.5), 500 mM NaCl, and 1 mM DTT. The columnwas calibrated using the gel-ﬁltration low molecular weight and
high molecular weight calibration kits from Amersham
Biosciences.
2.5. Steady-state kinetic assays
The rate of enzyme-catalyzed hydrolysis of p-nitrophenyl phos-
phate (PNPP) was determined at 25 or 37 C by monitoring the in-
crease in solution absorbance at 410 nm (De = 18.4 mM1 cm1).
The 0.5 ml assay mixtures contained 50 mM HEPES (pH 7.0) and
5 mM MgCl2. Hydrolysis reactions of all other phosphate esters
were monitored using the Enzcheck phosphate assay kit (Invitro-
gen). The enzyme-catalyzed phosphate release in solutions con-
taining 20 mM Tris–HCl, 2 mM MgCl2, and 2 mM sodium azide
(pH 7.5) was monitored at 25 C by measuring the increase in
absorbance at 360 nm.
Thioesterase activity was measured using a DTNB coupled as-
say. The reaction solutions (1 ml) contained speciﬁed concentra-
tions of substrate and 1 mM DTNB in 0.15 M KCl and 50 mM
HEPES (pH 7.5). The progress of the reaction was monitored at
412 nm.
Initial velocities of the reactions were measured as a function of
substrate concentrations (0.5- to 10-fold Km). The initial velocity
data were ﬁtted using Eq. (1) and the computer program KinetA-
syst to deﬁne Vmax and Km.
v ¼ Vmax½S=ð½S þ KmÞ ð1Þ
where v is the initial velocity, Vmax the maximum velocity, [S] the
substrate concentration, Km the Michaelis constant. The kcat values
were calculated from the ratios of Vmax and enzyme concentration.
ThepHdependenceof the catalysis of glycerophosphate hydroly-
sis by the BF1314 HAD domain was examined bymeasuring the kcat
and Km at pH 5–7.5. Reaction buffers contained various concentra-
tions of glycerophosphate, 2 mM MgCl2, 2 mM sodium azide,
50 mM acetate and 50 mM 2-(N-morpholino)ethanesulfonate
(MES) for pH 5.0–5.5, 50 mM Bis–Tris for pH 6.0–6.5, and 50 mM
HEPES for pH 7.0–7.5. The hydrolysis reactions were monitored as
described above using the Enzcheck phosphate assay kit at 25 C.
3. Results and discussion
3.1. Production of the fusion protein of the Bacteroidetes menaquinone
pathway
Fusion proteins, also known as chimeric proteins, are created by
a gene mutation that joins two protein-encoding genes to form a
single transcriptional unit. Provided that the full coding region of
each gene is preserved, the translation product is likely to assume
a fold that conserves the native structures and functions of the two
parent proteins, thus forming a single-chain, bifunctional protein.
Bifunctional enzymes that catalyze two (not necessarily succes-
sive) steps of a metabolic pathway are common to bacteria because
the genes encoding the pathway enzymes are often clustered on
the bacterial genome.
The fusion protein of the Bacteroidetes menaquinone pathway
consists of an N-terminal HAD phosphatase domain and a C-termi-
nal type AB hotdog-fold thioesterase domain. The amino-acid se-
quences of the fusion proteins identiﬁed via a BLAST search of
the NCBI gene databank is shown in Fig. SI1. Our initial hypothesis
was that the thioesterase domain catalyzes the hydrolysis of the
1,4-dihydroxynapthoyl-CoA, and that the HAD domain catalyzes
inorganic pyrophosphate hydrolysis. Inorganic pyrophosphate is
generated by the 2-succinylbenzoate-CoA synthase (MenE) of the
upper pathway and by 1,4-dihydroxynapthoate-octaprenyltrans-
ferase (MenA) of the lower pathway. In a previous study we had
shown that the HAD protein BT2127 of B. thetaiotaomicron is a
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drives the coupled reactions catalyzed by a bifunctional L-fucose
kinase/L-fucose 1-phosphate guanyltransferase forward via hydro-
lysis of the pyrophosphate product [41]. By analogy, the reaction
catalyzed by the HAD domain of the Bacteroidetes menaquinone
pathway fusion protein might be coupled with the reactions cata-
lyzed by MenE and/or MenA. In order to test the proposed func-
tions of the fusion proteins, the encoding genes from two species
of Bacteroides (thetaiotaomicron BT4699 and fragilis BF1314;
82.7% pairwise sequence identity) along with an encoding gene
from a more distant Bacteroidetes species, Porphyromonas gingiva-
lis PG1653 (43.0% and 42.1% pairwise sequence identity, respec-
tively) were cloned for overexpression in E. coli. The B.
thetaiotaomicron BT4699 was found to have limited solubility in
the His6-tagged and native forms and was therefore not pursued
further. PG1653 and BF1314 were puriﬁed to homogeneity and
subjected to steady-state kinetic analysis for thioesterase and
phosphatase activity, as was the thioesterase domain homolog
BVU2420 from B. vulgatus.Fig. 2. A: The structure of the hotdog-fold thioesterase ydiI from E. coli (PDB accession #
catalytic sites are highlighted by the red and blue colored stick representations of the key
3NIW) as represented by the monomer (catalytic domain is colored wheat and the cap
Depiction of the threading model (calculated using Phyre [55]) of BF1314 based on the ex
active site between the catalytic Rossmann-fold core domain (green) and substrate speciﬁ
sticks and Mg2+ cofactor as a magenta sphere. Residue numbering for BF1314 with the3.2. Catalytic activity of the hotdog-fold domain in the fusion protein
A search of the NCBI genebank using the program BLAST re-
vealed that the closest homologs to the fusion protein hotdog-fold
domains belong to the hotdog-fold PaaI/YdiI family. Members of
this family are type AB thioesterases, structurally represented
(Fig. 2A) by E. coli ydiI (38% sequence identity; PDB accession code
1VH5). The hotdog-fold domains of each of the Bacteroidetes fu-
sion proteins conserve the catalytic Glu (Glu333 using BF1314
numbering) residue that corresponds to Glu63 in the E. coli ydiI
and Glu58 in the B. vulgatus BVU2420 (see sequence logo in
Fig. 3 and sequence alignments in Figs SI1 and SI2). To demonstrate
that these proteins are indeed bona ﬁde thioesterases, they were
evaluated as catalysts for aroyl- and acyl-CoA hydrolysis by
measuring the steady-state rate constants kcat and Km for a panel
of thioesters (Table 1). It is evident from these results that aliphatic
acyl-CoA thioesters (C2–C14) are not viable physiological sub-
strates. In contrast, the three classes of aromatic ring-containing
thioesters (R–C(@O)SCoA where R = phenyl; R = napthyl; R =1VH5) as represented by the dimer (subunits shown in wheat and green). The two
catalytic residues. B: The structure of the HAD phosphatase BT3352 (PDB accession
domain green). The catalytic residues are shown as individually colored sticks. C:
perimental coordinates of BT3352 (PDB 3NIW; 47% sequence identity) depicting the
city cap domain (wheat) with conserved catalytic and supporting residues shown as
corresponding residue for BT3352 is in parenthesis.
M. Wang et al. / FEBS Letters 587 (2013) 2851–2859 2855CH2-phenyl) were found to be active substrates. Notably, BVU2420,
BF1314 and PG1653 displayed a clear preference for the napthyl
ring-containing thioester substrate. The respective kcat/Km values
(1  106 M1 s1) measured for the 1,4-dihydroxynapthoyl-CoA
thioester are sufﬁciently high as to suggest that it is the physiolog-
ical substrate. Furthermore, the observation that the 1,4-dihydrox-
ynapthoyl-CoA kcat/Km values are roughly two orders of magnitude
-CoA suggests specialization, based on ring hydroxyl group recog-
nition, for targeting 1,4-dihydroxynapthoyl-CoA. The presence of
the encoding genes in the respective menaquinone pathway geneFig. 3. The sequence logo generated from the alignment of the fusion proteins using the
asterisks.clusters (Fig. 1B) provides the biological context for the thioester-
ase-catalyzed 1,4-dihydroxynapthoyl-CoA hydrolysis.
3.3. The HAD domain in the fusion protein does not act as a
phosphatase
A BLAST search revealed that the closest homologs to the fusion
protein HAD domains belong to the cap type C2B structural class
(InterPro IPR006379) of the HAD enzyme superfamily and within
this class, the Cof family (InterPro IPR000150). Members of theserver at http://weblogo.berkeley.edu/logo.cgi. Catalytic residues marked with red
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(50% sequence identity with the HAD domain of BT4699) (see
Fig. 2B), are typically found to be promiscuous sugar phosphate
phosphatases (for examples see [42–44]). Examination of the
alignment of the sequences of BT3352 with the HAD domains of
BF1314 and BT4699 (Fig. SI3), and threading models of the HAD
domains of BF1314 (Fig. 2C) and BT4699 (not shown), indicate that
the catalytic sites of the BF1314 and BT4699 HAD domains are in-
tact. Speciﬁcally, using the numbering for BF1314 the Asp9 nucle-
ophile, Asp11 acid/base, Mg2+ cofactor-binding Asp200 and Asp224
and the substrate phosphate-binding residues Lys197 and Ser43
are present as is the Arg46 which positions the Asp11 acid/base
residue. These residues are strictly conserved among the fusion
proteins (see sequence logo in Fig. 3). However, a notable excep-
tion is the substitution of a Phe11 for Asp11 acid/base observed
for the PG1653 (see sequence alignment in Fig. SI3). Generally,
amino-acid replacement of the Asp acid/base residue in HAD
superfamily phosphatases ablates catalysis of organophosphate
hydrolysis (for examples see [42,44–47]). The replacement of AspTable 1
Steady-state kinetic constants for PG1653, BF1314 and BVU2420-catalyzed thioester hydr
Substrate Enzyme kcat (s1)
Butyryl-CoA PG1653 <104
BF1314 <104
BVU2420 (3.5 ± 0.1
Isobutyryl-CoA PG1653 <104
BF1314 <104
BVU2420 (2.2 ± 0.1
Hexanoyl-CoA PG1653 <104
BF1314 <104
BVU2420 (4.2 ± 0.2
Octanoyl-CoA PG1653 <104
BF1314 <104
BVU2420 (3.2 ± 0.3
Decanoyl-CoA PG1653 <104
BF1314 <104
BVU2420 <104
Myristoryl-CoA PG1653 <104
BF1314 <104
BVU2420 <104
1,4-Dihydroxynapthoyl-CoA PG1653 (1.0 ± 0.1
BF1314 (1.2 ± 0.1
BVU2420 (1.3 ± 0.1
Napthoyl-CoA PG1653 6.9 ± 0.2
BF1314 6.4 ± 0.3
BVU2420 4.6 ± 0.2
4-Hydroxybenzoyl-CoA PG1653 4.6 ± 0.1
BF1314 1.1 ± 0.1
BVU2420 1.2 ± 0.1
Benzoyl-CoA PG1653 (3.0 ± 0.1
BF1314 (2.4 ± 0.2
BVU2420 (2.8 ± 0.1
3-Hydroxyphenylacetyl-CoA PG1653 (3.1 ± 0.2
BF1314 (1.9 ± 0.1
BVU2420 (3.4 ± 0.1
Table 2
Steady-state kinetic constants for BF1314 and engineered BF1314 HAD domain-catalyzed h
for details.
Substrate BF1314
kcat (min1) Km (mM) kcat/Km
p-Nitrophenylphosphate <1  103 – –
Carbamoylphosphate 1.3 ± 0.1 0.44 ± 0.03 54
Imidodiphosphate 12.6 ± 0.6 5.7 ± 0.5 37
Acetylphosphate 0.48 ± 0.02 0.51 ± 0.04 16
3-Glycerophosphate <1  103 – –
3-Glycerophosphatea – – –
a Measured at pH 5.5.with Phe in PG1653 was observed for each of sequences derived
from three different P. gingivalis strains (Fig. SI3), and thus the
substitution cannot be attributed to a sequencing error.
Because PG1653 lacks the Asp acid/base we questioned its
ability to catalyze phosphate ester hydrolysis. However, we ex-
pected to observe BF1314 phosphohydrolase activity given that it
possesses a full set of catalytic residues, and that HAD phosphohy-
drolases display some degree of substrate promiscuity when
tested against a panel of phosphate ester and phosphate anhy-
dride metabolites [48]. Our initial hunch, that the HAD domain
of the fusion protein might function as a pyrophosphatase (vide
supra), was pursued by testing BF1314 and PG1653-catalyzed
hydrolysis of inorganic pyrophosphate; however, no activity was
detected. A second possibility, that these enzymes support the
lower menaquinone pathway by catalyzing the hydrolysis of
farnesyl-pyrophosphate (possible regulatory function) and/or
farnesyl-monophosphate (possible housekeeping function), was
also dismissed because neither compound is dephosphorylated
by BF1314 or PG1653.olysis measured at pH 7.5 and 25 C. See Section 2 for details.
km (lM) Km/kcat (M1s1)
– –
– –
)  102 (6.9 ± 0.2)  102 5.1  101
– –
– –
)  102 (6.1 ± 0.4)  102 3.6  101
– –
– –
)  102 (3.3 ± 0.3)  103 1.3  101
– –
– –
)  103 (1.7 ± 0.1)  104 1.9  101
– –
– –
– –
– –
– –
– –
)  101 4.0 ± 0.3 2.5  106
)  101 7.0 ± 0.5 1.7  106
)  101 (1.5 ± 0.1)  101 8.7  105
(1.7 ± 0.2)  102 4.0  104
(2.3 ± 0.4)  102 2.9  104
(1.8 ± 0.2)  102 2.5  104
(8.0 ± 0.6)  102 5.8  103
(2.3 ± 0.2)  102 4.7  103
(3.3 ± 0.2)  101 3.6  104
)  102 (5.8 ± 0.5)  101 5.2  102
)  102 (8.4 ± 0.8)  101 2.8  102
)  102 (3.1 ± 0.4)  101 9.0  102
)  101 (1.7 ± 0.3)  102 2.0  103
)  101 (4.6 ± 0.4)  101 4.1  103
)  102 (8.1 ± 0.6)  102 4.2  101
ydrolysis measured in the presence of 1 mM MgCl2 at pH 7.5 and 25 C. See Section 2
BF1314-HAD Domain
(M1s1) kcat (min1) Km (mM) kcat/Km (M1s1)
<1  103 – –
2.5 ± 0.02 0.97 ± 0.08 42
23 ± 1 7.4 ± 0.5 51
1.2 ± 0.1 0.87 ± 0.06 23
0.66 ± 0.06 0.063 ± 0.002 170
6.0 ± 0.6 0.087 ± 0.007 1100
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(wild-type and the Phe11Asp variant) were tested against of a vari-
ety of phosphate esters and phosphate anhydrides. Compounds
that showed no detectable substrate activity included adenosine-
50-triphosphate, adenosine-50-diphosphate, adenosine-50-mono-
phosphate, uridine-50-monophosphate, erythrose-4-phosphate,
fructose-1-phosphate, glucose-6-phosphate, a-glucose-1-phos-
phate, fructose-1,6-bisphosphate, thiamine phosphate, threonine
phosphate, serine phosphate, ribose-5-phosphate, arabinose-5-
phosphate, 2-keto-3-deoxy-6-phosphogluconate, 6-phosphoglu-
conic acid, glyceraldehyde-3-phosphate, 3-phosphoglycerate,
2-phosphoglycolate, phosphoenolpyruvate and p-nitrophenyl-
phosphate. BF1314, but not PG1653, displayed a very low level of
activity toward three substrates that are relatively susceptible to
spontaneous hydrolysis in solution, namely carbamoylphosphate,
imidodiphosphate and acetylphosphate (respective kcat/Km values
of 54 M1 s1, 37 M1 s1 and 16 M1 s1; Table 2).
The lack of phosphatase activity observed for BF1314 and
PG1653 stands in contrast to the phosphatase activity previously
reported for the homologous standalone HAD phosphatase
BT3352, which was used to generate the threading model of
BF1314 shown in Fig. 2C. BT3352 is highly efﬁcient in catalysis of
hydrolytic dephosphorylation of C4 and C5 sugar phosphates, with
the highest activity observed towards erythrose-4 phosphate (kcat/
Km = 1.3  105 M1 s1) [49]. Why then is BF1314 inactive? Is the
association of the HAD domain with the thioesterase domain in
some way inhibiting the phosphatase activity?
To pursue these questions we determined if the HAD domain
phosphatase activity could be restored by removal of the thioester-
ase domain.
3.4. Catalytic properties of the HAD domain and thioesterase domains
of BF1314
The BF1314 gene was engineered to express the N-terminal
HAD domain (residues 1–290) as a standalone protein. The HAD
domain C-terminus region was identiﬁed from the alignment of
the sequences of the Bacteroides fusion proteins with the corre-
sponding standalone HAD phosphatase homologs. The engineered
BF1314 HAD domain proved to be soluble and stable. However,
when screened against the substrate library, the high level of cat-
alytic activity observed for BT3352 was not found (Table 2). Never-
theless, a new activity was observed, namely the hydrolysis of the
phosphate ester, glycerophosphate. At pH 7.5 and 25 C catalysis
occurs with low efﬁciency (kcat/Km = 170 M1 s1), yet, when mea-
sured at pH 5.5, the efﬁciency is signiﬁcantly higher (kcat/
Km = 1100 M1 s1) (pH/rate proﬁle shown in Fig. SI4). Thus, the
catalytic site is functional, but only with this one phosphate ester.
Based on these ﬁndings we concluded that the engineered
BF1314 HAD domain is in fact a phosphatase, albeit an inefﬁcient
one. Given the importance of cap domain-catalytic domain associ-
ation for catalytic turnover, and dissociation for substrate binding
and product release [50], a likely scenario is that coordinated do-
main movement does not occur in the fusion proteins. At the
two extremes, the cap and catalytic domains might remain in a
partially closed conformation thereby limiting access of the sub-
strate to the catalytic site or alternatively, the two domains might
remain in an open conformation thereby preventing active site
desolvation. Because the removal of the thioesterase domain re-
stores a modest level of catalytic activity, albeit restricted to a
small substrate, we assume that it is the attached thioesterase do-
main that is perturbing cap function in the native enzyme.
If the HAD domain of the fusion protein does not function as a
catalyst, then what function might preserve its evolutionary part-
nership with the thioesterase domain? To address this question,
the thioesterase domain was tested for catalytic activity indepen-dent of the HAD domain. Accordingly, the BF1314 gene was engi-
neered to express the thioesterase domain as a standalone
protein (residues 274–410). The engineered thioesterase domain
protein proved to be soluble and stable during puriﬁcation. Yet,
when tested for 1,4-dihydroxynapthoyl-CoA thioesterase activity
it was catalytically inactive (viz. kcat <1  104 s1). Thus, the thio-
esterase domain requires the HAD domain for catalytic function.
Our next step was to explore the structural basis for this
requirement.
3.5. Effect of HAD and thioesterase domains on oligomerization state
To gain insight into the interaction between the HAD and thio-
esterase domains within the fusion protein, the ability of the engi-
neered BF1314 HAD domain and the BF1314 thioesterase domain
to form a stable complex was tested by gel ﬁltration chromatogra-
phy. In addition, the ability of the engineered BF1314 HAD domain
(residues 1–290) to restore catalytic activity to the engineered
BF1314 thioesterase domain was evaluated by steady-state kinetic
analysis. The 1:1 mixture of the two domains failed to catalyze the
hydrolysis of 1,4-dihydroxynapthoyl-CoA (SI Table 1). In addition,
the same mixture cleanly separated into a HAD domain fraction
and a thioesterase domain fraction on a gel-ﬁltration column
(Fig. SI5). These ﬁndings indicate that the two domains do not form
a stable complex. However, based on their elution proﬁles we
learned that the engineered HAD domain exists as a tetramer in
solution (monomer mass: 30 kDa; observed mass: 130 kDa) yet
the engineered thioesterase domain is a monomer in solution (cal-
culated monomer mass: 17 kDa; observed mass: 15 kDa). Be-
cause the active site of the hotdog-fold thioesterase is formed at
the interface of two associated subunits (Fig. 2A) the minimal bio-
logical unit (i.e., catalytically active species) is a dimer. Most typi-
cally the hotdog-fold thioesterase exists as a tetramer (viz. dimer of
dimer) [51,52], as is also found to be the case with the tetrameric
(native) BF1314 fusion protein (monomer mass: 47 kDa; observed
mass: 190 kDa determined by gel ﬁltration chromatography). Gi-
ven that the engineered BF1314 HAD domain is also a tetramer we
surmised that the HAD domain serves as an oligomerization do-
main. A priori, by reducing the entropy loss for thioesterase do-
main association, the strong association of the HAD domains
could augment weak association of the thioesterase domains.
And, by taking on this role, the HAD domain might ultimately lose
catalytic function. The absence of an evolutionary selection pres-
sure for catalytic function is indicated by the replacement of an
essential catalytic residue, namely the Asp acid/base in PG1653
(vide supra).
3.6. Bioinformatic analysis of sequence divergence, gene duplication,
and biological range
The B. fragilis BF1314 sequence was used as query in a BLAST
search of protein sequences deposited in the NCBI databank. The
biological range of the fusion protein is limited to the phyla Bacter-
oidetes and more speciﬁcally, to certain species of Bacteroides (cac-
cae, cellulosilyticus, clarus, coprosuis, eggerthii, fragilis, ﬁnegoldii,
ﬂuxus, helcogenes, intestinalis, ovatus, stercoris, uniformis, faecis, nor-
dii, oleiciplenus, salyersiae, thetaiotaomicron and xylanisolvens)
(80% sequence identity), Parabacteroides (merdae, johnsonii, gold-
steinii, distasonis and sp. D13) (75% sequence identity), Paraprev-
otella (clara, xylaniphila) (73% sequence identity), Tannerella
(forsythia) (73% sequence identity), Capnocytophaga (sp oral toxin
329) (73% sequence identity) and Porphyromonas (gingivalis, uenonis,
and asaccharolytica) (40% sequence identity). Except for P. gingivalis,
T. forsythia and Capnocytophaga which are members of the red
complex of periodontal pathogens, these fusion protein-producing
organisms are found in the upper or lowermammalian gastrointestinal
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lize menaquinone as the electron acceptor during energy metabolism.
Some of the sequenced genomes of species that possess the fu-
sion protein have been fully annotated, enabling inspection of gene
neighborhoods. In the case of the human gut bacteria B. fragilis and
thetaiotaomicron and P. distasonis and uenonis the fusion protein
gene is adjacent to the cluster of menb-f genes. In contrast, the
location of the fusion-protein genes is distant from themenb-f gene
cluster in the genome of the pig gut bacterium B. helcogenes. The
distant location of the fusion protein gene from the menb-f gene
cluster is also observed for the human bacteria Porphyromonas gin-
givalis, asaccharolytica and uenonis as well as in Paraprevotella
xylaniphila and Parabacteroides sp. D13.
We anticipated that Bacteroidetes/Chlorobi species, which do
not possess the fusion protein, yet do contain the genes encoding
the menaquinone pathway enzymes would necessarily have a
standalone thioesterase to function in place of the fusion protein.
Indeed, thioesterases sharing 49–56% sequence identity with the
BF1314 fusion protein thioesterase domain were found to be en-
coded by the genomes of Bacteroides species coprocola, coprophilus,
dorei, plebeius, salantitronis and vulgatus as well by the genomes of
the distant Bacteriodetes/Chlorobi species Cytophaga hutchinsonii,
Dokdonia donghaensis, Bizonia argentinensis, Flavobacteriales bacterium
ALC-1, Gramella forsetii, Kordia algicida, Lacinutrix sp. 5H-3-7-4,
Leeuwenhoekiella blandensis, Muricauda ruestringensis, Paludibacter
propionicigenes WB4, Zobellia galactanivorans, Zunongwangia pro-
funda and all represented Prevotella species. These latter thioester-
ases share 34–48% sequence identity with the BF1314 fusion
protein thioesterase domain. Notably, the thioesterase-encoding
genes are typically co-located with menaquinone pathway genes,
consistent with the participation of the thioesterases in the respec-
tive pathways. We characterized one such thioesterase from B.
vulgatus, BVU2420, to show that it catalyzes the hydrolysis of
1,4-dihydroxynapthoyl-CoA with high efﬁciency (kcat/Km = 1 
106 M1 s1; Table 2) (sequence alignment is shown in Fig. SI2)
and is thus an ortholog.
A majority of the sequenced genomes that encode the stand-
alone thioesterases also encode close homologs to the BF1314 fu-
sion protein HAD domain (>40% sequence identity). Intriguingly,
a signiﬁcant number of the bacteria that possess the fusion protein
also possess a standalone HAD phosphatase with >45% sequence
identity (Bacteroides caccae, clarus, fragilis, ﬁnegoldii, helcogenes,
thetaiotaomicron and xylanisolvens, Parabacteroides sp D13, Parap-
revotella xylaniphila and Capnocytophaga sp oral toxin 329). In con-
trast, we found no examples of bacteria that possess a standalone
thioesterase homolog in addition to the HAD-thioesterase fusion
protein.3.7. Conclusions
The HAD-thioesterase fusion proteins, examined here (PG1653
and BF1314) show highly efﬁcient thioesterase activity toward
the substrate 1,4-dihydroxynapthoyl-CoA. Together with this
in vitro activity, gene neighborhood analysis places these enzymes
ﬁrmly in the menaquinone pathway. However, the HAD domain of
the fusion protein is devoid of catalytic activity and most likely
takes on a scaffolding function. BT3352, a homologue with high se-
quence identity (35.8–47.1%) to the HAD domain of the fusion pro-
tein, efﬁciently catalyzes the hydrolysis of small sugar phosphates
[49]. Because a comparative model shows that the active sites of
the HAD domain of the fusion proteins are intact (with the excep-
tion of the catalytic acid/base in PG1653), the lack of phosphohy-
drolase activity can be attributed to changes over the entire
scaffold that effect catalysis and perhaps more speciﬁcally, todisruption of conformational coupling between the cap and core
domains.
We posit that following the fusion of the two functionally unre-
lated genes, the HAD and thioesterase domains co-evolved result-
ing in the loss of phosphohydrolase catalytic function in the HAD
domain and an acquired dependence of the thioesterase domain
on its HAD domain partner for oligomerization. In some Bacteroi-
detes species, a homologous yet independent thioesterase cata-
lyzes 1,4-dihydroxynapthoyl-CoA hydrolysis in the menaquinone
pathway, thus indicating that the fusion protein is the vestige of
a random mutation that linked the two encoding genes. Gene fu-
sions can confer many advantages. These include co-regulation of
gene expression for enzymes in a pathway, the insurance of the
stoichiometry of the gene products [53] or the regulation of subcel-
lular localization [54]. However, in the case of the fusion of the
HAD domain and thioesterase domain a very different outcome re-
sults, in which an independent thioesterase (exempliﬁed by
BVU2420) becomes structurally dependent on a HAD phosphatase
(exempliﬁed by BT3352) for oligomerization. The persistence of
the fusion protein is likely due to the requirement for catalysis of
1,4-dihydroxynapthoyl-CoA hydrolysis coupled with the absence
of a second copy of the 1,4-dihydroxynapthoyl-CoA thioesterase
gene. Unlike the HAD phosphatase we found no evidence for dupli-
cation of the thioesterase gene.
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